Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

Metabolism: Clinical and Experimental

Volumn 51, Issue 3, 2002, Pages 314-317

  Hirose, Hiroshi ^a,b,c   Kawai, Toshihide ^a,b,c   Yamamoto, Yukihiro ^a,b,c   Taniyama, Matsuo ^a,b,c   Tomita, Motowo ^a,b,c   Matsubara, Koichi ^a,b,c   Okazaki, Yasunori ^a,b,c   Ishii, Tatsuya ^a,b,c   Oguma, Yuko ^a,b,c   Takei, Izumi ^a,b,c   Saruta, Takao ^a,b,c  

^a KEIO UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Chugai Diagnostics Science Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIATHEROSCLEROTIC HORMONE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; SULFONYLUREA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIET RESTRICTION; DIET THERAPY; DOSE RESPONSE; DRUG EFFECT; HUMAN; INSULIN BLOOD LEVEL; JAPAN; LIPID BLOOD LEVEL; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036125944     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.30506     Document Type: Article

References (32)

1. Thiazolidinediones: An update
2. Pathogenesis of NIDDM. A balanced overview
3. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group
4. Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes
5. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes
6. Effect of troglitazone on body fat distribution in type 2 diabetic patients
7. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
8. Importance of intra-abdominal visceral fat accumulation to coronary atherosclerosis in heterozygous familial hypercholesterolaemia
9. Production of plasminogen activator inhibitor 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease
10. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)
11. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
12. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma
13. Organization of the gene for gelatin-binding protein (GBP28)
14. Regulation of gelatin-binding protein 28 (GBP28) gene expression by C/EBP
15. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls
16. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway
17. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances
18. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
19. Serum leptin level: Possible association with haematopoiesis in adolescents, independent of body mass index and serum insulin
20. The obese gene product, leptin: Possible role in obesity-related hypertension in adolescents
21. Relationships between baseline serum leptin levels and 2-year changes in body mass index, blood pressure and metabolic parameters in Japanese male adolescents and middle-aged men
22. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
23. Understanding "insulin resistance": Both glucose resistance and insulin resistance are required to model human diabetes
24. A novel technique for the determination of body fat by computed tomography
25. Dietary fat-induced increase in blood pressure and insulin resistance in rats
26. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives
27. Rosiglitazone
28. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus (T2DM)
29. Influences of ionomycin, dibutyryl-cyclo-AMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes
30. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance
31. Pioglitazone time-dependently reduces tumor necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats
32. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin